The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study-Reference-Cited by-同舟云学术

The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study

Published:2022-06-20 Issue:7 Volume:33 Page:663-670
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Özdemir Özlem,Zengel Baha,Yildiz Yaşar,Uluç Basak Oyan,Cabuk Devrim,Ozden Ercan,Salim Derya Kivrak,Paydas Semra,Demir Atakan,Diker Omer,Pilanci Kezban Nur,Sönmez Özlem Uysal,Vatansever Sezai,Dogan Izzet,Gulmez Ahmet,Cakar Burcu,Gursoy Pinar,Yildirim Mahmut Emre,Ayhan Murat,Karadurmus Nuri,Aykan Musa Baris,Cevik Gökcen Tugba,Sakalar Teoman,Hacibekiroglu Ilhan,Gülbagci Burcu Belen,Dincer Murat,Garbioglu Duygu Bayir,Kemal Yasemin,Nayir Erdinc,Taskaynatan Halil,Yilmaz Mesut,Avci Okan,Sari Murat,Coban Ezgi,Atci Muhammed Mustafa,Esen Selin Aktürk,Telli Tugba Akin,Karatas Fatih,Inal Ali,Demir Hacer,Kalkan Nurhan Onal,Yilmaz Cengiz,Tasli Funda,Alacacioglu Ahmet

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference35 articles.

1. Preoperative chemotherapy: updates of National surgical adjuvant breast and bowel project protocols B-18 and B-27.;Rastogi;J Clin Oncol,2008

2. Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL–CALGB 150007/150012, ACRIN 6657.;Esserman;J Clin Oncol,2012

3. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.;Carey;Clin Cancer Res,2007

4. Breast cancer molecular subtypes respond differently to preoperative chemotherapy.;Rouzier;Clin Cancer Res,2005

5. Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review.;Dawood;J Clin Oncol,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory breast cancer: Epidemiologic data and therapeutic results;International Review of Cell and Molecular Biology;2024

2. Antineoplastics;Reactions Weekly;2022-09-10